I. B. Skottheim

Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.

A. Åsberg, I. Skottheim, A. Gedde-Dahl, 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch

K. Stormark, A. Åsberg, T. Jenssen, 2010, Clinical pharmacology and therapeutics.

Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin

A. Åsberg, J. Røislien, J. Hjelmesæth, 2012, Surgical Endoscopy.

Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients

K. Stormark, A. Åsberg, T. Jenssen, 2009, Clinical pharmacology and therapeutics.

Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

T. Andersson, A. Åsberg, E. Molden, 2013, Clinical pharmacology and therapeutics.

Atorvastatin Metabolite Measurements as a Diagnostic Tool for Statin-Induced Myopathy

A. Åsberg, K. Retterstøl, M. Hermann, 2011, Molecular Diagnosis & Therapy.

Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

T. Andersson, E. Molden, J. Hjelmesæth, 2013, Clinical pharmacology and therapeutics.